Today in News History
On July 12, several notable moments in the history of News stand out. In 1580, The Ostrog Bible, one of the early printed Bibles in a Slavic language, is published. In 1691, Battle of Aughrim (Julian calendar): The decisive victory of William III of England's forces in Ireland. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1857, George E. Ohr, American potter (died 1918) was born. In 1909, Herbert Zim, American naturalist, author, and educator (died 1994) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1939, Phillip Adams, Australian journalist and producer was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 2010, Pius Njawé, Cameroonian journalist (born 1957) passed away. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.
Narrative Intelligence Brief
This article was published by ScienceDaily, a source frequently categorized with a Unknown bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of ScienceDaily, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from ScienceDaily
July 12, 2026
Columbia scientists discover surprising link between serotonin and heart valve disease
July 12, 2026
Yale scientists may have found how Parkinson's disease spreads through the brain
July 11, 2026
Experimental drug reverses severe fatty liver disease by repairing the gut
July 11, 2026
Second pregnancy changes the brain in surprising new ways
July 11, 2026
Physicists finally build a quantum material predicted more than a decade ago
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"wimbledon"
Sinner outlasts Zverev to win second straight Wimbledon title
Heartbreak for Cruz Hewitt as teen loses Wimbledon boys’ final thriller
Jannik Sinner receives Gentlemen's Singles Trophy from Catherine after Italian defends Wimbledon title
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 17%
Center 33%
Right 50%
Investing.com
· Jun 26, 2026
US FDA declines to approve Sobi’s therapy for uncontrolled gout
US FDA declines to approve Sobi’s therapy for uncontrolled gout
Seeking Alpha
· Jul 9, 2026
Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win
Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win
The Standard
· Jun 21, 2026
Weight loss pill to reshape spending habits of millions of people, study finds
The approval of the first oral pill this month will drive a more powerful shift in consumer habits, PwC found in a study.
Health News | Mail Online
· Jul 2, 2026
The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings
The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings
Medical Daily
· Jul 7, 2026
A New FDA-Approved Oral Weight Loss Pill Requires No Fasting: What Makes Foundayo Different from Other GLP-1 Drugs
FDA approved Foundayo (orforglipron) on April 1, 2026 — the only oral GLP-1 pill for weight loss you can take any time of day without fasting. Average weight loss: 12.4. Here's the breakdown.
Drudge Retort
· Jun 26, 2026
One 79-year-old Patient Given Unapproved Powerful Obesity Drug
Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.
Topics:
Related coverage for "New weight loss pill beats oral Ozempic in major trial": Investing.com — US FDA declines to approve Sobi’s therapy for uncontrolled gout. Seeking Alpha — Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win. The Standard — Weight loss pill to reshape spending habits of millions of people, study finds. Health News | Mail Online — The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings. Medical Daily — A New FDA-Approved Oral Weight Loss Pill Requires No Fasting: What Makes Foundayo Different from Other GLP-1 Drugs. Drudge Retort — One 79-year-old Patient Given Unapproved Powerful Obesity Drug